Advanced Accelerator Application SA (NASDAQ:AAAP)’s share price dropped 3.1% on Thursday . The company traded as low as $33.00 and last traded at $33.33, with a volume of 164,449 shares traded. The stock had previously closed at $34.40.

A number of equities analysts recently commented on AAAP shares. Canaccord Genuity reissued a “buy” rating on shares of Advanced Accelerator Application SA in a research note on Tuesday, May 31st. Zacks Investment Research raised Advanced Accelerator Application SA from a “sell” rating to a “hold” rating in a research note on Tuesday, July 5th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $35.67.

The company’s market capitalization is $1.24 billion. The stock’s 50 day moving average is $31.61 and its 200-day moving average is $31.90.

Advanced Accelerator Applications SA is a radiopharmaceutical company that develops, produces and sells molecular nuclear medicine (MNM), diagnostic and therapeutic products. The Company’s lead therapeutic candidate, Lutathera, is being developed for the treatment of midgut neuroendocrine tumors (NETs).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.